| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $20.79M | - | |
| CEO | 1.74M | $10.96M | -41,666 | |
| Other | 409.9K | $2.58M | - | |
| CFO | 409.1K | $2.57M | - | |
| Other | 339.5K | $2.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2023 | Rosenbaum David P.59 | Chief Development Officer | Sell | 3,000 | $4.63 | $13,887.90 | -2.6% | -28.2% | +56.0% | |
| Feb 21, 2023 | Rosenbaum David P.59 | Chief Development Officer | Sell | 4,508 | $3.00 | $13,528.51 | -0.9% | +21.1% | +189.1% | |
| Feb 21, 2023 | Rodriguez Susan45 | Chief Commercial Officer | Sell | 5,586 | $3.00 | $16,763.59 | -1.5% | +21.1% | +189.1% | |
| Feb 21, 2023 | Williams Laura A55 | Chief Medical Officer | Sell | 3,187 | $3.00 | $9,564.19 | -1.0% | +21.1% | +189.1% | |
| Feb 21, 2023 | Blanks Robert | See Remarks | Sell | 3,394 | $3.00 | $10,185.39 | -1.2% | +21.1% | +189.1% | |
| Feb 21, 2023 | Grammer Elizabeth A58 | See Remarks | Sell | 2,914 | $3.00 | $8,744.91 | -0.9% | +21.1% | +189.1% | |
| Feb 21, 2023 | Raab Michael56 | President &CEO | Sell | 13,449 | $3.00 | $40,360.45 | -1.5% | +21.1% | +189.1% | |
| Feb 21, 2023 | Felsch Robert Ora64 | See Remarks | Sell | 3,214 | $3.00 | $9,645.21 | -2.7% | +21.1% | +189.1% | |
| Feb 21, 2023 | Renz Justin A54 | Chief Financial Officer | Sell | 3,439 | $3.00 | $10,320.44 | -1.0% | +21.1% | +189.1% | |
| Nov 22, 2022 | Rosenbaum David P.59 | Chief Development Officer | Sell | 1,948 | $1.95 | $3,796.86 | -0.2% | +58.9% | +133.0% |